OSBP2 and ovarian carcinoma: Similarly, aberrant upregulation of ORP4 expression has been reported in tissues derived from individuals with ovarian cancer, and inhibiting ORP4 has been identified as a potential target for anti-cancer therapy (Bensen et al., 2021).